ResMed Logo

Noninvasive ventilation for obesity hypoventilation syndrome

Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity, daytime hypercapnia (increased carbon dioxide levels) and hypoxia (oxygen deprivation) during sleep after ruling out other disorders that may cause alveolar hypoventilation.

OHS is a chronic condition that has been linked with metabolic, hormonal and cardiovascular deficiencies. It has been shown to decrease quality of life and carries an increased risk of hospitalisation and death.1

The use of noninvasive ventilation in OHS patients has been shown to:

  • Normalise blood gases2 
  • Prolong survival2
  • Decrease pulmonary artery systolic pressure3
  • Increase exercise capacity3

Find out more about noninvasive ventilation on our dedicated ResMed page

More Articles

Noninvasive ventilation for acute respiratory failure
Non-invasive ventilation (NIV) is often used for patients with Chronic Obstructive Pulmonary Disease, but emerging evidence suggests that NIV can be used in treating other types of acute respiratory failure.
Noninvasive ventilation for COPD patients
Treatment of COPD with noninvasive ventilation (NIV) has been shown to be effective in treating acute exacerbations of COPD, assisting pulmonary rehabilitation in COPD patients, and providing benefits in managing chronic hypercapnic COPD patients.
Noninvasive ventilation for neuromusclar diseases in adults
Many chronic neuromuscular disorders lead to progressive respiratory muscle dysfunction. Non-invasive ventilation can help reduce daytime sleepiness while facilitating gas exchange and breathing.